Dr. Bujor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
72 E Concord St
Evans 501
Boston, MA 02118Phone+1 617-638-5830
Summary
- I am a board certified rheumatologist and physician-scientist specializing in the care of patients with scleroderma. My research focuses on the interaction between immunity and fibrosis in scleroderma, identification of new biomarkers of disease, and development and validation of novel outcomes measures for clinical trials in scleroderma. I also serve as the Associate Program Director for the Rheumatology Fellowship Program. My work has been recognized with several awards, including the Walter A. Coyle Memorial Research Grant and Established Investigator awards of the Scleroderma Foundation, and the Tobé and Stephen E. Malawista, MD, Endowment in Academic Rheumatology of the Rheumatology Research Foundation.
Clinical Expertise
- Systemic sclerosis, Linear scleroderma, Scleroderma-related cardiomyopathy, Scleroderma, SSc sine scleroderma
Education & Training
- Boston University Medical CenterFellowship, Rheumatology, 2015 - 2017
- Mount Auburn HospitalResidency, Internal Medicine, 2012 - 2015
- Iuliu Hatieganu University of Medicine and PharmacyClass of 1999
Certifications & Licensure
- MA State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Outstanding Mentor Award UROP, Boston University, Boston, MA, 2021
- Tobé and Stephen E. Malawista, MD, Endowment in Academic Rheumatology Rheumatology Research Foundation, 2020
- Walter A. Coyle Memorial Research Grant Award Scleroderma Foundation, 2010
Publications & Presentations
PubMed
- 9 citationsMetabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity.Mona Alotaibi, Junzhe Shao, Michael W Pauciulo, William C Nichols, Anna R Hemnes
Chest. 2023-01-01 - 64 citationsEndoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.Erin Morris, Izabela Chrobak, Andreea M. Bujor, Faye N. Hant, Christine L. Mummery
Journal of Cellular Physiology. 2011-12-01 - 60 citationsAngiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosisLukasz Stawski, Rong Han, Andreea M. Bujor, Maria Trojanowska
Arthritis Research & Therapy. 2012-08-22
Press Mentions
- Parenteral More Efficient Than Oral Methotrexate in Rheumatoid ArthritisOctober 7th, 2019
Grant Support
- The role of Fli1 in myeloid cells and its contribution to cardiac fibrosisNIH NHLBI2021–2026
Other Languages
- Romanian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: